...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Shareholder Value
8
Aug 06, 2021 10:32AM
1
Aug 06, 2021 09:33PM
6
Aug 06, 2021 10:09PM
2
Aug 07, 2021 08:46AM

Don missed an excellent opportunity to put out an IPO for Zenith in late 2019 before the top-line results were announced for RVX, BOM. He would have capitalized on the Apabetalone hype of the sister company Resverlogix and before "ZHCLF" started to trade and take hold on the OTC Market.

 

IMO ... Koo

6
Aug 07, 2021 01:41PM
1
Aug 07, 2021 01:43PM
Share
New Message
Please login to post a reply